After a career of over 30 years at bioMérieux, Henri Thomasson, Chief Financial Officer, has decided to take his retirement. In addition, Steve Harbin, Corporate Vice President of Manufacturing, Quality, Regulatory Affairs & Information Systems, has decided to embark on a new career as an entrepreneur. Jean-Luc Belingard, Chairman and Chief Executive Officer of bioMérieux, the Board of Directors and the members of the Management Committee thank Henri Thomasson and Steve Harbin for the significant contribution they have made and momentum they have given to the company's development.

Moving forward, the Management Committee will be organized as follows: Alexandre Mérieux, Directeur Général Délégué of the company, will lead Manufacturing Operations and Supply Chain. In addition, Alexandre Mérieux will continue to be Corporate Vice President of the Microbiology and Molecular Biology Unit. He will be managing a team of over 2,000 employees worldwide.

François Lacoste, Corporate Vice President of the Immunoassays Unit, will also be in charge of Quality. Mark Miller, Chief Medical Officer, will also oversee Regulatory Affairs. As of September 5, 2013, Claire Giraut will join bioMérieux's Management Committee.

She will begin as Head of the Information Systems (IS) and Purchasing departments. After a transition period with Henri Thomasson, she will assume responsibility for a new Administration and Finance Department enlarged to Purchasing and IS. Before joining bioMérieux, Claire Giraut held various positions as Chief Financial Officer.

Her latest assignments were with Ipsen and Europcar Groupe.